Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients

Reuters

2025/10/22

Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients

Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention $(PCI)$ in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2577369770"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577369770\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577369770?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577369770","market":"nz","top_or_hot":-1,"title":"Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention <a href=\"https://laohu8.com/S/PCI\">$(PCI)$</a> in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHeartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-10-22 20:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention <a href=\"https://laohu8.com/S/PCI\">$(PCI)$</a> in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4112","symbol_name":"金融交易所和數據","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL2bghhM:1","article_id":"2577369770","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577369770","pubTimestamp":1761134441,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention  in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics  2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.Disclaimer: This news bri","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4112":"金融交易所和数据","BK4585":"ETF&股票定投概念","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","HTFL":"HeartFlow Inc","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4167":"医疗保健技术","NDAQ":"纳斯达克OMX交易所","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4588":"碎股"},"translate_title":"Heartflow推出NAVIGATE-PCI注册，评估2,500名患者的人工智能引导PCI计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HTFL":0.9,"NDAQ":0.9},"content_text":"Heartflow Launches NAVIGATE-PCI Registry to Assess AI-Guided PCI Planning in 2,500 Patients\n    \n\n        Heartflow Inc. has announced new developments in clinical research and product offerings related to coronary intervention planning. The company's PLAN CALCIUM study evaluated the impact of integrating Heartflow Plaque Analysis with coronary CTA imaging and FFRCT analysis to inform interventional cardiologists' decisions on percutaneous coronary intervention $(PCI)$ in patients with highly calcified lesions. Data from the PLAN CALCIUM study will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, scheduled for October 26, 2025. Additionally, Heartflow will initiate the NAVIGATE-PCI Registry in 2026, enrolling approximately 2,500 patients across 30 U.S. sites. This registry will assess the effect of the company's PCI Navigator tool on physician confidence, procedural safety, efficiency, strategy, and patient outcomes compared to standard care. Heartflow will also demonstrate PCI Navigator at their exhibit booth during the TCT 2025 conference.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9549915-en) on October 22, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}